Pacer Advisors, Inc. Ardelyx, Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.89 - $9.31 $7,380 - $11,665	-1,253 Reduced 25.52%	3,656 $27,000
Q1 2024 May 10, 2024	BUY	$6.05 - $9.74 $29,699 - $47,813	4,909 New	4,909 $35,000
Q2 2021 Jul 21, 2021	SELL	$6.55 - $8.98 $25,518 - $34,986	-3,896 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$6.1 - $7.69 $9,528 - $12,011	1,562 Added 66.92%	3,896 $26,000
Q4 2020 Jan 20, 2021	SELL	$5.05 - $7.1 $5,181 - $7,284	-1,026 Reduced 30.54%	2,334 $15,000
Q3 2020 Oct 19, 2020	BUY	$5.25 - $7.08 $17,640 - $23,788	3,360 New	3,360 $18,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.